Hims & Hers Health (HIMS), Why Is Fresh Attention Building Now?

Simply Wall St.10-13

Hims & Hers Health (HIMS) just switched on its Hers platform in Australia, giving women nationwide access to its personalised telehealth services in a market projected for rapid digital health growth....

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2675035173?lang=en_US&edition=fundamental","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790","is_english":true,"pubTime":"2026-10-13 19:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2675035173","market":"sg","top_or_hot":-1,"title":"Hims & Hers Health (HIMS), Why Is Fresh Attention Building Now?","media":"Simply Wall St.","content":"<div>\n<p>Hims & Hers Health (HIMS) just switched on its Hers platform in Australia, giving women nationwide access to its personalised telehealth services in a market projected for rapid digital health growth....</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-hims-why-is-fresh-attention-building-now\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hims & Hers Health (HIMS), Why Is Fresh Attention Building Now?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHims & Hers Health (HIMS), Why Is Fresh Attention Building Now?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-10-13 19:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-hims-why-is-fresh-attention-building-now><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Hims & Hers Health (HIMS) just switched on its Hers platform in Australia, giving women nationwide access to its personalised telehealth services in a market projected for rapid digital health growth....</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-hims-why-is-fresh-attention-building-now\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4196","symbol_name":"保健护理服务","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-hims-why-is-fresh-attention-building-now","article_id":"2675035173","we_media_id":null,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6032000-choice2-card/1788952998790"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hims/hims-hers-health/news/hims-hers-health-hims-why-is-fresh-attention-building-now","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2675035173","pubTimestamp":1791891079,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Hims & Hers Health (HIMS) just switched on its Hers platform in Australia, giving women nationwide access to its personalised telehealth services in a market projected for rapid digital health growth.\nFor context, Hims & Hers Health shares now trade at US$30.64, and while the 30 day share price return of 11.38% and 7 day gain of 3.27% point to rebuilding momentum, the stock is still down over the past quarter and year to date, with a 1 year total shareholder return that has declined 44.02%...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4196":"保健护理服务","HEAL":"Global X HealthTech ETF","THNR":"AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF","HIMS":"Hims & Hers Health Inc.","HIMY":"Defiance Leveraged Long + Income HIMS ETF","HMYY":"GraniteShares YieldBoost HIMS ETF","HIMC":"Corgi HIMS 2x Daily ETF","GLAM":"Corgi Beauty, Skincare & Aesthetics ETF","HIMZ":"DEFIANCE DAILY TARGET 2X LONG HIMS ETF","HIYY":"YieldMax HIMS Option Income Strategy ETF"},"translate_title":"HIMS和她的健康（HIMS），为什么现在新的注意力正在建立？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GLAM":0.6,"HIMS":1.98,"HEAL":0.6,"HIMC":0.6,"HIMY":0.6,"HIMZ":0.6,"HMYY":0.6,"HIYY":0.6,"THNR":0.6},"content_text":"Hims & Hers Health (HIMS) just switched on its Hers platform in Australia, giving women nationwide access to its personalised telehealth services in a market projected for rapid digital health growth. For context, Hims & Hers Health shares now trade at US$30.64, and while the 30 day share price return of 11.38% and 7 day gain of 3.27% point to rebuilding momentum, the stock is still down over the past quarter and year to date, with a 1 year total shareholder return that has declined 44.02% even after very large gains over the past three and five years. Compare how Hims & Hers Health stacks up against other digital health and telemedicine plays by reviewing our hand picked 33 healthcare AI stocks before you decide where momentum might build next. Fresh Australian expansion on one side, a sharp 1 year share price decline on the other. Does it make more sense to lean into Hims & Hers Health at this point, or to insist on a cheaper entry and wait? AdvertisementMost Popular Narrative: 82% Undervalued On Simply Wall St, the most followed narrative now pegs Hims & Hers Health at a fair value of $171.19, far above the last close at $30.64. This frames the current share price as a steep discount in that view.  The thesis is not about one medication, one category or one quarter. It is about a company repeatedly following the same playbook while expanding its addressable market. More customers. More categories. More countries. More services per customer. Higher ARPU. Better operating leverage. That is the Multi-Dimensional Growth Engine. The combination of execution, expanding opportunity and improving economics suggests that the disconnect between Hims' underlying growth potential and current market pricing remains substantial, both in the short and long term.  See why 81 investors see Hims & Hers Health as 82% undervalued. Result: Fair Value of $171.19 (UNDERVALUED) Still, this story can break if international rollouts underperform expectations, or if weight loss partnerships shift in ways that weaken the broader Hims & Hers Health thesis. Find out about the key risks to this Hims & Hers Health narrative. Another View: What Hims & Hers Health’s Sales Multiple Is Telling You The story shifts once you look at Hims & Hers Health through its P/S ratio. At 2.8x sales, the stock trades more expensively than both peers at 2.2x and the broader US Healthcare group at 1.3x, yet it is still below an estimated fair ratio of 4.6x. Is that a safety margin or a value trap forming? To pressure test that question using a simple comparison tool, take a look at our breakdown of this valuation gap and what it could mean for future upside or downside risk, starting with the See what the numbers say about this price — find out in our valuation breakdown.. Here is how the current pricing compares visually with sector levels and the fair ratio anchor, using P/S as the yardstick, in NYSE:HIMS P/S Ratio as at Oct 2026Next Steps If this mix of optimism and caution around Hims & Hers Health feels familiar, treat it as your signal to move quickly, pull up the data, and stress test the story against your own expectations. To see how the positives stack up against the concerns in one place, review the 2 key rewards and 1 important warning sign Looking for more investment ideas beyond Hims & Hers Health? Use this Hims & Hers Health check as a springboard and keep building your watchlist with fresh ideas that fit your risk, income, and quality targets.  Target potential bargains that pair solid fundamentals with appealing entry points by scanning our 29 high quality undervalued stocks. Lock in income-focused opportunities by reviewing a curated set of companies known for resilient payouts through the 8 dividend fortresses. Prioritise resilience and capital protection by reviewing a 31 resilient stocks with low risk scores that is designed to highlight businesses with stronger risk profiles.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Hims &amp; Hers Health might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2675035173","isCrawlerRequest":true}